DJ Amgen Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slipped 1.40% to $361.13 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.25% to 6,716.09 and the Dow Jones Industrial Average rising 0.10% to 46,993.26.
Amgen Inc. closed 7.71% short of its 52-week high of $391.29, which the company reached on March 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 2.09% to $238.11, Pfizer Inc. $(PFE)$ rose 3.16% to $27.45, and AbbVie Inc. $(ABBV)$ fell 0.76% to $219.76.
Trading volume (2.3 M) remained 439,950 below its 50-day average volume of 2.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 17, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments